PL3007772T3 - Kompozycje do zastosowania w leczeniu dyslipidemii w przewlekłej chorobie nerek - Google Patents

Kompozycje do zastosowania w leczeniu dyslipidemii w przewlekłej chorobie nerek

Info

Publication number
PL3007772T3
PL3007772T3 PL14744159T PL14744159T PL3007772T3 PL 3007772 T3 PL3007772 T3 PL 3007772T3 PL 14744159 T PL14744159 T PL 14744159T PL 14744159 T PL14744159 T PL 14744159T PL 3007772 T3 PL3007772 T3 PL 3007772T3
Authority
PL
Poland
Prior art keywords
dyslipidaemia
compositions
treatment
kidney disease
chronic kidney
Prior art date
Application number
PL14744159T
Other languages
English (en)
Inventor
Pier Luigi Guasti
Original Assignee
Difass International S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Difass International S.R.L. filed Critical Difass International S.R.L.
Publication of PL3007772T3 publication Critical patent/PL3007772T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14744159T 2013-06-14 2014-06-12 Kompozycje do zastosowania w leczeniu dyslipidemii w przewlekłej chorobie nerek PL3007772T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000989A ITMI20130989A1 (it) 2013-06-14 2013-06-14 Composizioni antidislipidemiche e loro uso
EP14744159.6A EP3007772B1 (en) 2013-06-14 2014-06-12 Compositions for use in the treatment of dyslipidaemia in chronic kidney disease
PCT/IB2014/062170 WO2014199333A1 (en) 2013-06-14 2014-06-12 Antidyslipidaemic compositions and use thereof

Publications (1)

Publication Number Publication Date
PL3007772T3 true PL3007772T3 (pl) 2018-08-31

Family

ID=49035693

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14744159T PL3007772T3 (pl) 2013-06-14 2014-06-12 Kompozycje do zastosowania w leczeniu dyslipidemii w przewlekłej chorobie nerek

Country Status (9)

Country Link
EP (1) EP3007772B1 (pl)
ES (1) ES2668931T3 (pl)
HU (1) HUE039153T2 (pl)
IT (1) ITMI20130989A1 (pl)
PL (1) PL3007772T3 (pl)
PT (1) PT3007772T (pl)
RS (1) RS57172B1 (pl)
TR (1) TR201807019T4 (pl)
WO (1) WO2014199333A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108294296A (zh) * 2018-01-17 2018-07-20 福建清道夫生物工程有限公司 一种功能性红曲组合物及其制备方法
US12115211B2 (en) * 2020-10-02 2024-10-15 Edgar Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171285A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Substances for reducing occurrence of major cardiac events comprising omega-3 polyunsaturated fatty acid or derivatives thereof and high-monacolin k content red yeast rice extract
US20120171311A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Substances for reducing occurrence of major cardiac events comprising epa or derivatives thereof, optionally, dha or derivatives thereof and monacolin k
US20120172425A1 (en) * 2007-06-01 2012-07-05 Opheim Joar A Red yeast rice extract high in monacolin k content

Also Published As

Publication number Publication date
ES2668931T3 (es) 2018-05-23
HUE039153T2 (hu) 2018-12-28
EP3007772B1 (en) 2018-02-21
WO2014199333A1 (en) 2014-12-18
TR201807019T4 (tr) 2018-06-21
RS57172B1 (sr) 2018-07-31
ITMI20130989A1 (it) 2014-12-15
EP3007772A1 (en) 2016-04-20
PT3007772T (pt) 2018-05-16

Similar Documents

Publication Publication Date Title
HUE039687T2 (hu) Kompozíciók, amelyek alkalmazhatók KIT-tel kapcsolatos rendellenességek kezelésében való alkalmazásra
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
ZA201506487B (en) Therapeutic compounds and compositions
PL3811943T3 (pl) Związek do stosowania w leczeniu zaburzeń oczu
ZA201505003B (en) Solid solution compositions and use in chronic inflammation
GB201320729D0 (en) Therapeutic compounds and their use
DK3730136T3 (da) Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom
SG11201508167PA (en) Therapeutic compositions and uses thereof
ZA201605051B (en) Multiprotease therapeutics for chronic pain
GB2516051B (en) Surgical tables
GB201311361D0 (en) Compounds and their therapeutic use
IL246162B (en) Angiotensin II, alone or in combination, to treat low blood pressure
PL2777671T3 (pl) Stół dla pacjenta
IL242584B (en) An immunogenic preparation for use in treatment
SG11201601490XA (en) Risk markers for cardiovascular disease in patients with chronic kidney disease
PL3071192T3 (pl) Związek kurkufenol do zastosowania w leczeniu nowotworu
IL258567A (en) Colloidal particles for use in medicine
GB201308736D0 (en) Compounds and their therapeutic use
PT3007772T (pt) Composições para utilização no tratamento de dislipidemia em doença renal crónica
IL241284A0 (en) Use of shroom3 in chronic kidney disease and chronic allograft nephropathy
GB2510477B (en) Formulations for use in the treatment of chronic fatigue and associated conditions, etc
GB201304675D0 (en) Novel compositions having use in therapy
PL2928461T3 (pl) Leczenie przewlekłej choroby nerek
ZA201508585B (en) Immunogenic composition for use in therapy
FI10319U1 (fi) Sovitelma saunan lauteissa